Amarin’s Vascepa prevents second and third heart attacks in analysis

Amarin’s Vascepa prevents second and third heart attacks in analysis

Amarin’s Vascepa prevents second and third heart attacks in analysis, fueling debate

By MATTHEW HERPER

AMARIN

With Vascepa, first heart problems were cut by 25 percent, second ones by 32 percent, third events by 31 percent, and fourth events by 48 percent.

READ MORE